Breaking: Definium Lands Positive Phase 3, LSD Candidate Shows Strong Antidepressant Effect

This morning, Definium Therapeutics announced positive topline results from its Phase 3 study of LSD (DT120) for major depressive disorder (MDD). It’s the first Phase 3 data for LSD, and for Definium.

Source